biotech
biotech Articles
Proteostasis Therapeutics shares pulled back on Tuesday after the company announced that it would be conducting a secondary offering.
Published:
Last Updated:
Mirati shares dropped on Monday after the company announced updated positive clinical data from its midstage study in non-small cell lung cancer.
Published:
Last Updated:
Medical technology company Axonics Modulation Technologies is offering more than 6 million shares in an initial public offering valued up to more than $122 million.
Published:
Last Updated:
Here is a preview of some of the world’s largest players in the health care sector reporting earnings this coming week.
Published:
Last Updated:
Here are five biotech stocks that are rated Buy by the Jefferies analysts, are trading under the $10 level and could provide investors with some solid upside potential.
Published:
Last Updated:
Clovis Oncology shares dropped on Friday after the company announced initial data from its Phase 2 clinical trial of Rubraca at the ESMO 2018 Congress.
Published:
Last Updated:
Merrimack Pharmaceuticals shares dropped early on Friday after the company announced that it would be terminating its midstage SHERLOC study in patients with non-small cell lung cancer.
Published:
Last Updated:
Genome editing company LogicBio Therapeutics expects to price more than 5 million shares for an initial public offering valued up to almost $93 million.
Published:
Last Updated:
Proteostasis Therapeutics shares absolutely exploded on Thursday after the company announced positive preliminary results from its early-stage cystic fibrosis trial.
Published:
Last Updated:
Endocyte shares were up sharply early Thursday after it was announced that the company would be acquired.
Published:
Last Updated:
Synthetic biology company Twist Bioscience expects to price 5 million shares for an initial public offering valued up to more than $103 million.
Published:
Last Updated:
Tetraphase Pharmaceuticals shares were up handily on Friday after the company announced the U.S. commercial launch of Xerava (eravacycline) for the treatment of complicated intra-abdominal infections.
Published:
Last Updated:
Corium shares jumped on Friday after the company announced that it entered into a definitive merger agreement under which Gurnet Point Capital will acquire Corium.
Published:
Last Updated:
Compugen shares pushed higher on Thursday after it was announced that Bristol-Myers Squibb will make a $12 million equity investment as part of its collaboration on a cancer trial.
Published:
Last Updated: